Literature DB >> 29119611

Task-dependent function of striatal cholinergic interneurons in behavioural flexibility.

Kana Okada1,2, Kayo Nishizawa3, Susumu Setogawa3, Kouichi Hashimoto1, Kazuto Kobayashi3.   

Abstract

Flexible switching of behaviours depends on integrative functioning through the neural circuit connecting the prefrontal cortex and the dorsomedial striatum (DMS). Although cholinergic interneurons modulate striatal outputs by diverse synaptic mechanisms, the roles of cholinergic interneurons in the DMS appear to vary among different models used to validate behavioural flexibility. Here, we conducted immunotoxin-mediated cell targeting of DMS cholinergic interneurons and examined the functions of these interneurons in behavioural flexibility, with the learning conditions differing in trial spacing and discrimination type in a modified T-maze. Elimination of the DMS cholinergic cell group normally spared reversal learning in place discrimination with an intertrial interval (ITI) of 15 s, but it impaired the reversal performance in response discrimination with the same ITI. In contrast, DMS cholinergic elimination resulted in enhanced reversal performance in both place and response discrimination tasks with a 10-min ITI and accelerated the reversal of response discrimination with a 20-min ITI. Our previous study also showed an enhanced influence of cholinergic targeting on place reversal learning with a 20-min ITI, and the present results demonstrate that DMS cholinergic interneurons act to inhibit both place and response reversal performance with a relatively longer ITI, whereas their functions differ between types of reversal performance in the tasks with a shorter ITI. These findings suggest distinct roles of the DMS cholinergic cell group in behavioural flexibility dependent on the trial spacing and discrimination type constituting the learning tasks.
© 2017 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Keywords:  intertrial interval; place discrimination; response discrimination; reversal learning; transgenic rat

Mesh:

Year:  2017        PMID: 29119611     DOI: 10.1111/ejn.13768

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  7 in total

1.  Complex Movement Control in a Rat Model of Parkinsonian Falls: Bidirectional Control by Striatal Cholinergic Interneurons.

Authors:  Cassandra Avila; Aaron Kucinski; Martin Sarter
Journal:  J Neurosci       Date:  2020-06-18       Impact factor: 6.167

2.  Regional Striatal Cholinergic Involvement in Human Behavioral Flexibility.

Authors:  Tiffany Bell; Michael Lindner; Angela Langdon; Paul Gerald Mullins; Anastasia Christakou
Journal:  J Neurosci       Date:  2019-05-20       Impact factor: 6.167

3.  Striatal Cholinergic Interneurons Are a Novel Target of Corticotropin Releasing Factor.

Authors:  Julia C Lemos; Jung Hoon Shin; Veronica A Alvarez
Journal:  J Neurosci       Date:  2019-05-20       Impact factor: 6.167

4.  Nicotinic Acetylcholine Receptors Expressed by Striatal Interneurons Inhibit Striatal Activity and Control Striatal-Dependent Behaviors.

Authors:  Alice Abbondanza; Irina Ribeiro Bas; Martin Modrak; Martin Capek; Jessica Minich; Alexandra Tyshkevich; Shahed Naser; Revan Rangotis; Pavel Houdek; Alena Sumova; Sylvie Dumas; Veronique Bernard; Helena Janickova
Journal:  J Neurosci       Date:  2022-02-14       Impact factor: 6.709

5.  Striatal Cholinergic Interneurons Are Required for Contending Strategy Selection While Solving Spatial Navigation Problems.

Authors:  Juan P Beccaria; Carlos A Pretell Annan; Ettel Keifman; M Gustavo Murer; Juan E Belforte
Journal:  J Neurosci       Date:  2021-12-21       Impact factor: 6.709

Review 6.  Basal ganglia mechanisms in action selection, plasticity, and dystonia.

Authors:  Jonathan W Mink
Journal:  Eur J Paediatr Neurol       Date:  2018-01-17       Impact factor: 3.140

7.  Dopamine D2Rs coordinate cue-evoked changes in striatal acetylcholine levels.

Authors:  Kelly M Martyniuk; Arturo Torres-Herraez; Daniel C Lowes; Marcelo Rubinstein; Marie A Labouesse; Christoph Kellendonk
Journal:  Elife       Date:  2022-07-20       Impact factor: 8.713

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.